Furthermore, our results indicated that anorexigenic IGF1 signaling occurs within the hypothalamus and that hyperinsulinemia-induced insulin resistance coincided with IGF1 resistance, potentially revealing a new mechanism contributing to obesity. The gene discussed is IGF1; the disease is obesity disorder.